- Filed
- Nov 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 3, 2025 | 14.87M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 15.4M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 15.35M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 15.19M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 15.14M sh |
| Stock Repurchased | Q3 2025 · Sep 30, 2025 | $2.29M |
| Stock Repurchased restated | Q3 2025 · Sep 30, 2024 | $0 |
| Capex | Q3 2025 · Sep 30, 2025 | $1.15M |
| Capex | Q3 2025 · Sep 30, 2024 | $901.39K |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$1.06M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | $5.28M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $29.7M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $25.05M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2024 | $20.74M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $22.7M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $20.65M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $33.05M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $49.04M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $46.66M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $62.48M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $60.5M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $74.58M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $69.39M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $83.15M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $0.06 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $0.12 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.21 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.39 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $0.06 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $0.12 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.21 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.39 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $10.56M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $32.97M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $10.33M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $31.81M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $160.92K |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$1.66M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$492.82K |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$2.7M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $2.66M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $8.41M |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $2.81M |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $8.33M |